Cargando…

Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies

Detalles Bibliográficos
Autores principales: Ribeiro, Carla Maria Pedrosa, McElvaney, Noel Gerard, Cabrini, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632627/
https://www.ncbi.nlm.nih.gov/pubmed/34867428
http://dx.doi.org/10.3389/fphar.2021.794854
_version_ 1784607785686663168
author Ribeiro, Carla Maria Pedrosa
McElvaney, Noel Gerard
Cabrini, Giulio
author_facet Ribeiro, Carla Maria Pedrosa
McElvaney, Noel Gerard
Cabrini, Giulio
author_sort Ribeiro, Carla Maria Pedrosa
collection PubMed
description
format Online
Article
Text
id pubmed-8632627
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86326272021-12-02 Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies Ribeiro, Carla Maria Pedrosa McElvaney, Noel Gerard Cabrini, Giulio Front Pharmacol Pharmacology Frontiers Media S.A. 2021-11-04 /pmc/articles/PMC8632627/ /pubmed/34867428 http://dx.doi.org/10.3389/fphar.2021.794854 Text en Copyright © 2021 Ribeiro, McElvaney and Cabrini. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Ribeiro, Carla Maria Pedrosa
McElvaney, Noel Gerard
Cabrini, Giulio
Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
title Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
title_full Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
title_fullStr Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
title_full_unstemmed Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
title_short Editorial: Novel Anti-Inflammatory Approaches for Cystic Fibrosis Lung Disease: Identification of Molecular Targets and Design of Innovative Therapies
title_sort editorial: novel anti-inflammatory approaches for cystic fibrosis lung disease: identification of molecular targets and design of innovative therapies
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632627/
https://www.ncbi.nlm.nih.gov/pubmed/34867428
http://dx.doi.org/10.3389/fphar.2021.794854
work_keys_str_mv AT ribeirocarlamariapedrosa editorialnovelantiinflammatoryapproachesforcysticfibrosislungdiseaseidentificationofmoleculartargetsanddesignofinnovativetherapies
AT mcelvaneynoelgerard editorialnovelantiinflammatoryapproachesforcysticfibrosislungdiseaseidentificationofmoleculartargetsanddesignofinnovativetherapies
AT cabrinigiulio editorialnovelantiinflammatoryapproachesforcysticfibrosislungdiseaseidentificationofmoleculartargetsanddesignofinnovativetherapies